Ligia N Laranjeira
Overview
Explore the profile of Ligia N Laranjeira including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
694
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Maia I, Kawano-Dourado L, Tramujas L, de Oliveira N, Souza R, Signorini D, et al.
JAMA
. 2024 Dec;
333(10):875-890.
PMID: 39657981
Importance: High-flow nasal oxygen (HFNO) and noninvasive ventilation (NIV) are commonly used respiratory support therapies for patients with acute respiratory failure (ARF). Objective: To assess whether HFNO is noninferior to...
2.
Zampieri F, Westphal G, Santos M, Gomes S, Gomes J, Negrelli K, et al.
J Crit Care
. 2024 Aug;
84:154892.
PMID: 39096659
Purpose: To assess the effect of antisense therapy to block kallikrein-kinin pathway in COVID-19 patients. Material And Methods: Randomized, placebo-controlled, double blind, controlled trial enrolling hospitalized COVID-19 patients that required...
3.
Siuba M, Bulgarelli L, Duggal A, Cavalcanti A, Zampieri F, Rey D, et al.
Chest
. 2024 May;
166(4):754-764.
PMID: 38768777
Background: ARDS is a heterogeneous condition with two subphenotypes identified by different methodologies. Our group similarly identified two ARDS subphenotypes using nine routinely available clinical variables. However, whether these are...
4.
Maia I, Kawano-Dourado L, Zampieri F, Damiani L, Nakagawa R, Gurgel R, et al.
Crit Care Resusc
. 2023 Dec;
24(1):61-70.
PMID: 38046839
The best way to offer non-invasive respiratory support across several aetiologies of acute respiratory failure (ARF) is presently unclear. Both high flow nasal catheter (HFNC) therapy and non-invasive positive pressure...
5.
Duggal A, Kast R, Van Ark E, Bulgarelli L, Siuba M, Osborn J, et al.
BMJ Open
. 2022 Jan;
12(1):e053297.
PMID: 34992112
Objectives: The acute respiratory distress syndrome (ARDS) is a heterogeneous condition, and identification of subphenotypes may help in better risk stratification. Our study objective is to identify ARDS subphenotypes using...
6.
Cavalcanti A, Zampieri F, Rosa R, Azevedo L, Veiga V, Avezum A, et al.
N Engl J Med
. 2020 Jul;
383(21):2041-2052.
PMID: 32706953
Background: Hydroxychloroquine and azithromycin have been used to treat patients with coronavirus disease 2019 (Covid-19). However, evidence on the safety and efficacy of these therapies is limited. Methods: We conducted...
7.
Berwanger O, de Barros E Silva P, Dall Orto F, de Andrade P, de Castro Bienert I, Bosso C, et al.
Am Heart J
. 2018 Apr;
198:129-134.
PMID: 29653634
Background: Previous evidence suggests that acute treatment with statins reduce atherosclerotic complications, including periprocedural myocardial infarction, but currently, there are no large, adequately powered studies to define the effects of...
8.
Berwanger O, Guimaraes H, Laranjeira L, Cavalcanti A, Kodama A, Zazula A, et al.
JAMA
. 2012 Jun;
307(19):2041-9.
PMID: 22665103
Context: Studies have found that patients with acute coronary syndromes (ACS) often do not receive evidence-based therapies in community practice. This is particularly true in low- and middle-income countries. Objective:...
9.
Berwanger O, Guimaraes H, Laranjeira L, Cavalcanti A, Kodama A, Zazula A, et al.
Am Heart J
. 2012 Mar;
163(3):323-29, 329.e1.
PMID: 22424001
Translating evidence into clinical practice in the management of acute coronary syndromes (ACS) is challenging. Few ACS quality improvement interventions have been rigorously evaluated to determine their impact on patient...